Abstract

Call for Abstracts


We are excited to announce the Call for Abstracts for the upcoming Qatar Radiology Congress (QRC 2025), the premier event dedicated to exploring the latest trends, sharing knowledge, and networking with peers. We look forward to your contributions and to an inspiring event.

Abstract Submission Guidelines


Abstract submission deadline is Thursday, 31 July 2025 at 11:59 pm (Qatar Local Time). Please review guidelines below prior to abstract submission.

Abstract Type/Format:

Abstracts can be a Scientific Abstract/Research, Case Reports or Educational Exhibit; should be submitted in English (Up to 400 words) preferably in the following format (in addition to title, author names and institution):

​Scientific/Research OR Educational Exhibit:

Case Reports:

Purpose / Objectives 
Introduct​ion and History
Materials & Methods / Background 
Imaging Findings and Figures
Results / Discussion 
Discussion
Conclusion 
Conclusion
Tables and Figures (if applicable) 
References (optional)
References (optional)


A​dditional information:

  • The abstract must be submitted by the presenting author, and his/her contact information including email address is required. Authors of accepted abstracts will be notified via email.
  • Abstracts can be selected for either an oral presentation or electronic poster.
  • Abstracts selected for oral presentations will be strictly limited to a 10-minute presentation if Scientific Abstract/Research OR a 5-minute presentation if Educational Posters or Case Reports.
  • Submitted abstracts that are not accepted for oral presentation will be evaluated for presentation in an electronic poster format. If accepted as an e-poster, authors will be notified, and they may be asked to provide appropriate digital copy for presentation (PDF or PowerPoint) if needed.
  • There is no limit to the number of abstracts authors may submit. Please ensure all details of the presenting author and co-authors are included.
  • Please indicate potential conflicts of interest for all authors and outline all relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services may be related to the subject matter.
  • Accepted abstracts will be published online in the conference archive viewing platform.
  • If you wish to withdraw your abstract after submission, or if you have any questions, please send an email to DTan1@hamad.qa and APattassery@hamad.qa.

DISCLAIMER

The organizers of this event take no responsibility for the abstracts submitted, any issues arising from the abstracts are the responsibility of the authors.

By submitting their work, the author(s) consent to publishing the abstracts on the conference website and potentially in the Clinical Imaging Department Newsletter, and transfer and assign the rights to prepare derived works such as press releases to the scientific planning committee. Author(s) represents and warrants that the work is original and does not infringe upon any copyrights. If the work is not original, the author(s) should reference the original source and ensure all relevant permission and/or authorization for re-use is obtained.​​